Khondrion features in new video from Catalyze-Group®

find more articles

Khondrion Secures EU Orphan Drug Designation for Lead Compound Sonlicromanol in Treatment of Inherited Mitochondrial Oxidative Phosphorylation Defects

Clarifying the Phenotypic Spectrum of m.3243A>G: A Proposal for Terminological Precision in PMD

Khondrion Secures up to €5 Million Innovation Credit from Dutch Government plus Additional Funding from Current Investors to Advance Phase 3 Clinical Trial in m.3243A>G Primary Mitochondrial Disease

view all articles